Gilead Sciences, Inc. (BIT:1GILD)
Italy flag Italy · Delayed Price · Currency is EUR
92.49
-1.16 (-1.24%)
Last updated: Apr 17, 2025

Gilead Sciences Revenue

In the year 2024, Gilead Sciences had annual revenue of $28.75B USD with 6.04% growth. Gilead Sciences had revenue of $7.57B in the quarter ending December 31, 2024, with 6.40% growth.

Revenue
$28.75B
Revenue Growth
+6.04%
P/S Ratio
4.13
Revenue / Employee
$1.63M
Employees
17,600
Market Cap
114.61B EUR

Revenue Chart

* This company reports financials in USD.

History

Fiscal Year End Revenue Change Growth
Dec 31, 202428.75B1.64B6.04%
Dec 31, 202327.12B-165.00M-0.60%
Dec 31, 202227.28B-24.00M-0.09%
Dec 31, 202127.31B2.62B10.60%
Dec 31, 202024.69B2.24B9.98%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Recordati Industria Chimica e Farmaceutica 2.34B
DiaSorin 1.19B
Amplifon 2.41B
Philogen 77.65M
EL.En. 565.85M
Pharmanutra 116.15M
Garofalo Health Care 467.77M
Safilo Group 993.22M
Revenue Rankings